Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: Findings from the High-Risk Myocardial Infarction Database Initiative

European Journal of Heart Failure

Volumn 17, Issue 11, 2015, Pages 1144-1151

  Von Lueder, Thomas G ^a,b   Girerd, Nicolas ^c,d,e,f   Atar, Dan ^a,b   Agewall, Stefan ^a,b   Lamiral, Zohra ^c,d,e,f   Kanbay, Mehmet ^g   Pitt, Bertram ^h   Dickstein, Kenneth ⁱ   Zannad, Faiez ^c,d,e,f   Rossignol, Patrick ^c,d,e,f  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c INSERM   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e UNIVERSITÉ DE LORRAINE   (France)

^f CRIN   (France)

^g KOÇ UNIVERSITY   (Turkey)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF BERGEN   (Norway)

Author keywords

Heart failure; Left ventricular dysfunction; Myocardial infarction; Uric acid

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; URIC ACID; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; META ANALYSIS; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SURVIVAL; URIC ACID BLOOD LEVEL; AGED; BLOOD; COMPLICATION; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICS; STATISTICS AND NUMERICAL DATA;

AGED; BIOMARKERS; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STATISTICS AS TOPIC; URIC ACID; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84955176428     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.419     Document Type: Article

References (26)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB,. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-e292.
2. Zhao G, Huang L, Song M, Song Y,. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis 2013; 231: 61-68.
3. Kawai T, Ohishi M, Takeya Y, Onishi M, Ito N, Yamamoto K, Kamide K, Rakugi H,. Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients. Hypertens Res 2012; 35: 1087-1092.
4. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML,. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474-480.
5. Chen X, Li Y, Sheng CS, Huang QF, Zheng Y, Wang JG,. Association of serum uric acid with aortic stiffness and pressure in a Chinese workplace setting. Am J Hypertens 2010; 23: 387-392.
6. Bandukwala F, Huang M, Zaltzman JS, Nash MM, Prasad GV,. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk. Am J Cardiol 2009; 103: 867-871.
7. Niizeki T, Takeishi Y, Arimoto T, Okuyama H, Nozaki N, Hirono O, Tsunoda Y, Watanabe T, Nitobe J, Miyashita T, Takahashi H, Koyama Y, Kubota I,. Hyperuricemia associated with high cardiac event rates in the elderly with chronic heart failure. J Cardiol 2006; 47: 219-228.
8. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA,. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res 2010; 62: 170-180.
9. Pascual-Figal DA, Hurtado-Martinez JA, Redondo B, Antolinos MJ, Ruiperez JA, Valdes M,. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail 2007; 9: 518-524.
10. Huang H, Huang B, Li Y, Huang Y, Li J, Yao H, Jing X, Chen J, Wang J,. Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail 2014; 16: 15-24.
11. Levantesi G, Marfisi RM, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Silletta MG, Tavazzi L, Tognoni G, Marchioli R,. Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction. Int J Cardiol 2013; 167: 262-269.
12. Kaya MG, Uyarel H, Akpek M, Kalay N, Ergelen M, Ayhan E, Isik T, Cicek G, Elcik D, Sahin O, Cosgun SM, Oguzhan A, Eren M, Gibson CM,. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012; 109: 486-491.
13. Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M, Tei C, Hiraoka H, Sonoda M, Tsuchihashi K, Shimoyama N, Honda T, Ogata Y, Matsui K, Ogawa H,. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 2005; 96: 489-495.
14. Dickstein K, Bebchuk J, Wittes J,. The high-risk myocardial infarction database initiative. Prog Cardiovasc Dis 2012; 54: 362-366.
15. Stewart LA, Tierney JF,. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 2002; 25: 76-97.
16. Inglis SC, Bebchuk J, Al-Suhaim SA, Case J, Pfeffer MA, Solomon SD, Hou YR, Pitt B, Dargie HJ, Ford I, Kjekshus J, Zannad F, Dickstein K, McMurray JJ,. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. Int J Cardiol 2013; 168: 1094-1101.
17. Moukarbel GV, Yu ZF, Dickstein K, Hou YR, Wittes JT, McMurray JJ, Pitt B, Zannad F, Pfeffer MA, Solomon SD,. The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients. Eur J Heart Fail 2014; 16: 289-299.
18. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M,. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Publ Health 2004; 4: 9.
19. Pencina MJ, D'Agostino RB, Sr., D'Agostino RB Jr, Vasan RS,. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172; discussion 207-212.
20. Uno H, Tian L, Cai T, Kohane IS, Wei LJ,. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med 2013; 32: 2430-2442.
21. Puddu PE, Bilancio G, Terradura Vagnarelli O, Lombardi C, Mancini M, Zanchetti A, Menotti A,. Serum uric acid and eGFR-CKDEPI differently predict long-term cardiovascular events and all causes of deaths in a residential cohort. Int J Cardiol 2014; 171: 361-367.
22. Yang Y, Fan Y, Li J, Liu B, Shao Y, Cao H, Wang J, Zou R, Zhang Q, Hu X,. Serum uric acid as a predictor for cardiovascular and all-cause mortality in women versus men. Int J Cardiol 2015; 185: 125-128.
23. Alimonda AL, Nunez J, Nunez E, Husser O, Sanchis J, Bodi V, Minana G, Robles R, Mainar L, Merlos P, Darmofal H, Llacer A,. Hyperuricemia in acute heart failure. More than a simple spectator? Eur J Intern Med 2009; 20: 74-79.
24. Savarese G, Ferri C, Trimarco B, Rosano G, Dellegrottaglie S, Losco T, Casaretti L, D'Amore C, Gambardella F, Prastaro M, Rengo G, Leosco D, Perrone-Filardi P,. Changes in serum uric acid levels and cardiovascular events: a meta-analysis. Nutr Metab Cardiovasc Dis 2013; 23: 707-714.
25. Hirsch GA, Bottomley PA, Gerstenblith G, Weiss RG,. Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts. J Am Coll Cardiol 2012; 59 (9): 802-8.
26. Foell D, Wittkowski H, Roth J,. Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nat Clin Pract Rheumatol 2007; 3: 382-390.